CV Sciences, Inc. (CVSI)
| Market Cap | 8.64M |
| Revenue (ttm) | 15.85M |
| Net Income (ttm) | -2.53M |
| Shares Out | 184.79M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,870 |
| Open | 0.0451 |
| Previous Close | 0.0452 |
| Day's Range | 0.0451 - 0.0451 |
| 52-Week Range | 0.0300 - 0.1000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2024 |
About CV Sciences
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements
Designed to elevate focus, mood, energy, and metabolism with clinically proven wellness ingredients Available in three variations - Clarity, Peace, and ReShape SAN DIEGO , Aug. 27, 2024 /PRNewswire/ -...
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024
GAINERS: Target Group (OTC: CBDY) shares closed up 33.33% at $0.00 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 28.57% at $0.01 Nextleaf Solutions (OTC: OILFF) shares closed up 19.05% at $0.07...
CV Sciences, Inc. (CVSI) Q2 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q2 2024 Earnings Conference Call August 13, 2024 10:00 AM ETCompany ParticipantsBrendan Hawkins - Investor RelationsJoseph...
CV Sciences, Inc. Reports Second Quarter 2024 Financial Results
SAN DIEGO , Aug. 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024
SAN DIEGO , Aug. 7, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. (CVSI) Q1 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q1 2024 Earnings Conference Call May 14, 2024 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participants...
CV Sciences, Inc. Reports First Quarter 2024 Financial Results
SAN DIEGO , May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024
SAN DIEGO , May 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ot...
CV Sciences, Inc. (CVSI) Q4 2023 Earnings Call Transcript
CV Sciences, Inc. (CVSI) Q4 2023 Earnings Call Transcript
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
SAN DIEGO , March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ...
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
Pet Hip and Joint Health Chews and Pet Calming Care Chews improve the physical and emotional well-being of dogs SAN DIEGO , March 26, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company...
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
SAN DIEGO , March 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in nutraceuticals an...
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
SAN DIEGO , Dec. 12, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. (CVSI) Q3 2023 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q3 2023 Earnings Conference Call November 14, 2023 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg G...
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
SAN DIEGO , Nov. 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ot...
CV Sciences, Inc. Launches Reserve Sleep Gummies
Premium sleep aid supports better sleep by combining melatonin and cannabinoids SAN DIEGO , Sept. 5, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "...
CV Sciences, Inc. (CVSI) Q2 2023 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q2 2023 Earnings Conference Call August 14, 2023 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participa...
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
SAN DIEGO , Aug. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023
SAN DIEGO , Aug. 1, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences to Participate in LD Micro Invitational Conference
13th invitational event welcomes over 150 companies to over 800 attendees SAN DIEGO , June 1, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), ...
CV Sciences, Inc. (CVSI) Q1 2023 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q1 2023 Earnings Conference Call May 15, 2023 10:00 AM ET Company Participants Joseph Dowling - CEO, Secretary and Director Joerg Grasser - CFO Conference Call Participa...
CV Sciences, Inc. Reports First Quarter 2023 Financial Results
SAN DIEGO , May 15, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023
SAN DIEGO , May 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and oth...